Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A review of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease.

Drug metabolism and drug interactions - 1 Jan 2001

Steventon G B, Sturman S, Waring R H, Williams A C

Abstract excerpt

The role of xenobiotic metabolising enzymes (XMEs) in disease aetiology has been under investigation by numerous researchers around the world for the last two decades. The association of a number of defects in both phase I and phase II reactions with Parkinson's disease (PD) and motor neuron disease (MND) have been extensively studied. This review of the work of the group based initially at the University of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Methylation
Share to Methyltransferases
Share to Monoamine Oxidase

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Motor Neuron Disease

Share to Oxidation-Reduction

Share to Parkinson Disease

Share to Statistics, Nonparametric

Share to Xenobiotics

Source

Identifiers

PMID: 11460878
DOI: 10.1515/dmdi.2001.18.2.79

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A review of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease.PMID 11460878Read ↗

An investigation into the inter-relationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases.Semantic proximity Read ↗

Phenylalanine 4-monooxygenase and the role of endobiotic metabolism enzymes in xenobiotic biotransformation.Semantic proximity Read ↗

Abnormal liver enzyme-mediated metabolism in Parkinson's disease: a second look.Semantic proximity Read ↗

Phenotypic variation in xenobiotic metabolism and adverse environmental response: focus on sulfur-dependent detoxification pathways.Semantic proximity Read ↗

Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease?Semantic proximity Read ↗

Liver enzyme abnormalities in Parkinson's disease.Semantic proximity Read ↗

Phenylalanine hydroxylase: A biomarker of disease susceptibility in Parkinson's disease and Amyotrophic lateral sclerosis.Semantic proximity Read ↗

Studies in alkaptonuria reveal new roles beyond drug clearance for phase I and II biotransformations in tyrosine metabolismSemantic proximity Read ↗

Flavin-containing monooxygenase 3 and human disease.Semantic proximity Read ↗

Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA TreatmentSemantic proximity Read ↗

P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson's disease.Semantic proximity Read ↗

Inborn errors of pyrimidine degradation: Clinical, biochemical and molecular aspectsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.